Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 26, 2021 - Issue 1
Submit an article Journal homepage
234
Views
5
CrossRef citations to date
0
Altmetric
Review

Emerging drugs for the treatment of basal cell carcinoma

Florian HermsDepartment of Dermatology, Université De Paris, Hôpital Saint-Louis, Paris, FranceCorrespondence[email protected]
View further author information
&
Nicole Basset-SeguinDepartment of Dermatology, Université De Paris, Hôpital Saint-Louis, Paris, FranceView further author information
Pages 17-26 | Received 11 Nov 2020, Accepted 06 Jan 2021, Published online: 24 Jan 2021

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Alessia Villani, Massimiliano Scalvenzi, Giuseppe Micali, Fabrizio Martora, Francesco Cillo, Flavia Raia & Luca Potestio. (2023) An update on the current and emerging pharmacotherapies for basal cell carcinomas. Expert Opinion on Pharmacotherapy 0:0, pages 1-9.
Read now

Articles from other publishers (4)

Isabella J. Tan, Gaurav N. Pathak & Frederick H. Silver. (2023) Topical Treatments for Basal Cell Carcinoma and Actinic Keratosis in the United States. Cancers 15:15, pages 3927.
Crossref
Rainer Kunstfeld & Van Anh Nguyen. (2023) Neue Entwicklungen in der Behandlung des Basalzellkarzinoms. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 21:4, pages 382-385.
Crossref
Rainer Kunstfeld & Van Anh Nguyen. (2023) New therapeutic developments for basal cell carcinoma. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 21:4, pages 382-385.
Crossref
Izabela Łasińska, Aleksandra Zielińska, Jacek Mackiewicz & Eliana B. Souto. (2022) Basal Cell Carcinoma: Pathology, Current Clinical Treatment, and Potential Use of Lipid Nanoparticles. Cancers 14:11, pages 2778.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.